Evidence map›Paper›PMID 29559892›Full record

ArticleFrontiers in cellular neuroscience2018

Robin Cloarec, Sylvian Bauer, Natacha Teissier, Fabienne Schaller, Hervé Luche, Sandra Courtens, Manal Salmi, Vanessa Pauly, Emilie Bois, Emilie Pallesi-Pocachard and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The immunology of sickness metabolism.Cellular & molecular immunology · 2024
    Review
  6. Article
  7. Role of microglia in brain development after viral infection.Frontiers in cell and developmental biology · 2024
    Review
  8. Review
  9. Review
  10. CNS Macrophages and Infant Infections.Frontiers in immunology · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Robin CloarecINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Sylvian BauerINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Natacha TeissierFrench National Institute of Health and Medical Research INSERM U1141, Paris Diderot University, Sorbonne Paris Cité, Paris, France.
Fabienne SchallerINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Hervé LucheCentre National de la Recherche Scientifique CNRS UMS3367, CIPHE (Centre D'Immunophénomique), French National Institute of Health and Medical Research INSERM US012, PHENOMIN, Aix-Marseille University, Marseille, France.
Sandra CourtensINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Manal SalmiINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Vanessa PaulyLaboratoire de Santé Publique EA 3279, Faculté de Médecine Centre d'Evaluation de la Pharmacodépendance-Addictovigilance de Marseille (PACA-Corse) Associé, Aix-Marseille University, Marseille, France.
Emilie BoisFrench National Institute of Health and Medical Research INSERM U1141, Paris Diderot University, Sorbonne Paris Cité, Paris, France.
Emilie Pallesi-PocachardINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Emmanuelle BuhlerINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
François J MichelINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Pierre GressensFrench National Institute of Health and Medical Research INSERM U1141, Paris Diderot University, Sorbonne Paris Cité, Paris, France.
Marie MalissenCentre National de la Recherche Scientifique CNRS UMS3367, CIPHE (Centre D'Immunophénomique), French National Institute of Health and Medical Research INSERM US012, PHENOMIN, Aix-Marseille University, Marseille, France.
Thomas StammingerInstitute for Clinical and Molecular Virology, University of Erlangen-Nuremberg, Erlangen, Germany.
Daniel N StreblowVaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR, United States.
Nadine BruneauINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Pierre SzepetowskiINMED, French National Institute of Health and Medical Research INSERM U1249, Aix-Marseille University, Marseille, France.
Inserm · FRInstitut de Neurobiologie de la Méditerranée · FRAix-Marseille Université · FRUniversité Paris Cité · FRCentre National de la Recherche Scientifique · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital cytomegalovirus (CMV) infections represent one leading cause of neurodevelopmental disorders. Recently, we reported on a rat model of CMV infection of the developing brain

Indexed as

cytomegalovirusfetal brainmicroglianeurological outcomerat model

Identifiers

PMID29559892
PMCPMC5845535
OpenAlexW2789937138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.